Essential gene profiles in breast, pancreatic, and ovarian cancer cells.
Essential gene profiles in breast, pancreatic, and ovarian cancer cells.
复制标题
DOI:
10.1158/2159-8290.cd-11-0224
复制
发表时间:
2012-02
期刊:
影响因子:
28.2
通讯作者:
Moffat J
中科院分区:
文献类型:
--
作者:
Marcotte R;Brown KR;Suarez F;Sayad A;Karamboulas K;Krzyzanowski PM;Sircoulomb F;Medrano M;Fedyshyn Y;Koh JLY;van Dyk D;Fedyshyn B;Luhova M;Brito GC;Vizeacoumar FJ;Vizeacoumar FS;Datti A;Kasimer D;Buzina A;Mero P;Misquitta C;Normand J;Haider M;Ketela T;Wrana JL;Rottapel R;Neel BG;Moffat J
Genomic analyses are yielding a host of new information on the multiple genetic abnormalities associated with specific types of cancer. A comprehensive description of cancer-associated genetic abnormalities can improve our ability to classify tumors into clinically relevant subgroups, and, on occasion, identify mutant genes that drive the cancer phenotype (“drivers”). More often, though, the functional significance of cancer-associated mutations is difficult to discern. Genome-wide pooled shRNA screens enable global identification of the genes essential for cancer cell survival and proliferation, providing a “functional genomic” map of human cancer to complement genomic studies. Using a lentiviral shRNA library targeting ~16,000 genes and a newly developed, dynamic scoring approach, we identified essential gene profiles in 72 breast, pancreatic, and ovarian cancer cell lines. Integrating our results with current and future genomic data should facilitate the systematic identification of drivers, unanticipated synthetic lethal relationships, and functional vulnerabilities of these tumor types.